Ha habido 50 transacciones internas recientes registradas para CVS Health Corporation (CVS), incluyendo 30 compras y 17 ventas. El total de compras internas fue valorado en $26.38M y el total de ventas internas en $6.6M.
Internos destacados con actividad reciente incluyen Nelson Steven H, Joyner J. David, Khichi Samrat S.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — CVS
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-04-01 |
Nelson Steven H |
EVP and President, Aetna |
Retención Fiscal de RSU |
2,432 |
$72.49 |
$176.3K |
2,900 |
| 2026-04-01 |
Joyner J. David |
President, CEO and Chair |
Retención Fiscal de RSU |
8,029 |
$72.49 |
$582.02K |
70,349 |
| 2026-04-01 |
Khichi Samrat S. |
EVP, CPO and General Counsel |
Retención Fiscal de RSU |
3,541 |
$72.49 |
$256.69K |
33,421 |
| 2026-04-01 |
Capozzi Heidi B |
EVP and Chief People Officer |
Retención Fiscal de RSU |
1,334 |
$72.49 |
$96.7K |
13,023 |
| 2026-04-01 |
Clark James David |
SVP, Cont & Chief Acct Officer |
Retención Fiscal de RSU |
3,262 |
$72.49 |
$236.46K |
15,457 |
| 2026-04-01 |
Mandadi Tilak |
EVP, Chief Exp & Tech Officer |
Retención Fiscal de RSU |
3,634 |
$72.49 |
$263.43K |
79,684 |
| 2026-04-01 |
Shah Prem S |
EVP and Group President |
Retención Fiscal de RSU |
1,484 |
$72.49 |
$107.58K |
64,356 |
| 2026-03-31 |
Nelson Steven H |
EVP and President, Aetna |
Concesión de RSU |
22,277 |
$71.82 |
$1.6M |
43,606 |
| 2026-03-31 |
Joyner J. David |
President, CEO and Chair |
Concesión de RSU |
86,326 |
$71.82 |
$6.2M |
160,860 |
| 2026-03-31 |
Khichi Samrat S. |
EVP, CPO and General Counsel |
Concesión de RSU |
12,531 |
$71.82 |
$899.98K |
38,139 |
| 2026-03-31 |
Capozzi Heidi B |
EVP and Chief People Officer |
Concesión de RSU |
64,670 |
$71.82 |
$4.64M |
64,670 |
| 2026-03-31 |
Compton-phillips Amy |
EVP, Chief Medical Officer |
Concesión de RSU |
35,928 |
$71.82 |
$2.58M |
35,928 |
| 2026-03-31 |
Clark James David |
SVP, Cont & Chief Acct Officer |
Concesión de RSU |
11,976 |
$71.82 |
$860.12K |
11,976 |
| 2026-03-31 |
Newman Brian |
EVP, Chief Financial Officer |
Concesión de RSU |
19,493 |
$71.82 |
$1.4M |
41,354 |
| 2026-03-31 |
Mandadi Tilak |
EVP, Chief Exp & Tech Officer |
Concesión de RSU |
22,277 |
$71.82 |
$1.6M |
88,543 |
| 2026-03-31 |
Shah Prem S |
EVP and Group President |
Concesión de RSU |
25,062 |
$71.82 |
$1.8M |
62,852 |
| 2026-03-19 |
Gallina John E |
Director |
Desconocido |
- |
- |
- |
- |
| 2026-03-19 |
Gallina John E |
Director |
Concesión de RSU |
582 |
$71.86 |
$41.82K |
582 |
| 2026-02-28 |
Joyner J. David |
President and CEO |
Retención Fiscal de RSU |
1,944 |
$79.90 |
$155.33K |
49,996 |
| 2026-02-28 |
Khichi Samrat S. |
EVP, CPO and General Counsel |
Retención Fiscal de RSU |
7,886 |
$79.60 |
$627.73K |
29,775 |
| 2026-01-01 |
Shah Prem S |
EVP and Group President |
Retención Fiscal de RSU |
247 |
$80.13 |
$19.79K |
61,509 |
| 2025-12-01 |
Clark James David |
SVP, Cont & Chief Acct Officer |
Retención Fiscal de RSU |
220 |
$79.10 |
$17.4K |
24,401 |
| 2025-11-30 |
Farah Roger N |
Director |
Retención Fiscal de RSU |
9,748 |
$80.36 |
$783.35K |
19,438 |
| 2025-11-30 |
Capozzi Heidi B |
EVP and Chief People Officer |
Retención Fiscal de RSU |
9,470 |
$80.36 |
$761.01K |
11,415 |
| 2025-11-30 |
Mandadi Tilak |
EVP, Chief Exp & Tech Officer |
Retención Fiscal de RSU |
6,575 |
$80.36 |
$528.37K |
74,085 |
| 2025-11-20 |
Brown C David Ii |
Director |
Concesión de RSU |
1,775 |
$76.04 |
$134.97K |
127,772 |
| 2025-11-20 |
Aguirre Fernando |
Director |
Concesión de RSU |
1,800 |
$76.04 |
$136.87K |
40,950 |
| 2025-11-20 |
Robbins Larry |
Director |
Concesión de RSU |
2,203 |
- |
- |
8,080 |
| 2025-11-20 |
Decoudreaux Alecia A |
Director |
Concesión de RSU |
1,652 |
- |
- |
40,054 |
| 2025-11-20 |
Kirby J Scott |
Director |
Concesión de RSU |
1,652 |
$76.04 |
$125.62K |
12,987 |
| 2025-11-20 |
Sansone Guy P |
Director |
Concesión de RSU |
1,652 |
$76.04 |
$125.62K |
13,659 |
| 2025-11-20 |
Finucane Anne A. |
Director |
Concesión de RSU |
591 |
$76.04 |
$44.94K |
591 |
| 2025-11-20 |
Mahoney Michael F |
Director |
Concesión de RSU |
2,022 |
- |
- |
4,613 |
| 2025-11-20 |
Norwalk Leslie V |
Director |
Concesión de RSU |
1,652 |
$76.04 |
$125.62K |
5,929 |
| 2025-11-20 |
Shulman Douglas H. |
Director |
Concesión de RSU |
1,652 |
$76.04 |
$125.62K |
5,929 |
| 2025-11-20 |
Balser Jeffrey R. |
Director |
Concesión de RSU |
1,775 |
$76.04 |
$134.97K |
13,659 |
| 2025-08-31 |
Mandadi Tilak |
EVP, Chief Exp & Tech Officer |
Retención Fiscal de RSU |
12,834 |
$73.15 |
$938.81K |
63,952 |
| 2025-08-31 |
Shah Prem S |
EVP and Group President |
Retención Fiscal de RSU |
6,995 |
$73.15 |
$511.68K |
60,632 |
| 2025-08-20 |
Finucane Anne A. |
Director |
Venta Informativa |
7,500 |
$71.02 |
$532.65K |
22,156 |
| 2025-06-05 |
Sansone Guy P |
Director |
Compra Informativa |
1,570 |
$63.70 |
$100.01K |
12,007 |
| 2025-05-31 |
Compton-phillips Amy |
EVP, Chief Medical Officer |
Concesión de RSU |
27,081 |
$64.04 |
$1.73M |
27,081 |
| 2025-05-31 |
Newman Brian |
EVP, Chief Financial Officer |
Concesión de RSU |
21,861 |
$64.04 |
$1.4M |
21,861 |
| 2025-05-19 |
Compton-phillips Amy |
EVP, Chief Medical Officer |
Desconocido |
- |
- |
- |
35 |
| 2025-05-19 |
Compton-phillips Amy |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-05-15 |
Brown C David Ii |
Director |
Concesión de RSU |
2,232 |
$60.47 |
$134.97K |
125,997 |
| 2025-05-15 |
Aguirre Fernando |
Director |
Concesión de RSU |
2,263 |
$60.47 |
$136.84K |
39,150 |
| 2025-05-15 |
Robbins Larry |
Director |
Concesión de RSU |
2,770 |
- |
- |
5,767 |
| 2025-05-15 |
Decoudreaux Alecia A |
Director |
Concesión de RSU |
2,077 |
- |
- |
37,765 |
| 2025-05-15 |
Kirby J Scott |
Director |
Concesión de RSU |
2,769 |
$60.47 |
$167.44K |
11,335 |
| 2025-05-15 |
Sansone Guy P |
Director |
Concesión de RSU |
2,077 |
$60.47 |
$125.6K |
10,437 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento